As investors we do not have all the answers to what operations Mr. Stadnyk is perusing but I see the CEO as a smart business man who likely has a solid plan. Time will tell and he has asked patience in this regard and a time window of about another 10 days to complete his due diligence on all the workings of this anticipated acquisition. He may even be looking at grouping several smaller operations together and an eye to our Southern neighbor (US) as a possible theater for the new business to operate in.
Another important tool for an investor is communication. In this regards Supreme Pharmaceuticals has been excellent in timing PR as real news becomes available. Not daily like some would like, but very soon after the news is relevant and concrete. The website is updated often and shows many characteristics not often seen on venture exchange companies that operate in the dark.
News 
Market Data 
Discover 
